Drug Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Trials & Filings
Stealth & Evotec Advance New Compound
Stealth expects to advance new pipeline candidate to clinical-stage studies by the end of 2019 using Evotec's INDiGO platform08.14.18
-
Collaborations & Alliances | Drug Development
Evotec AG, Haplogen Partner with Bayer in COPD
Aims to develop new antiviral compounds to reduce COPD exacerbation08.14.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Mustang Bio, St. Jude Partner for X-SCID
Most common form of severe combined immunodeficiency, affecting approximately one in 50,000 to 100,000 newborns worldwide08.13.18
-
Drug Development | Industry News
-
Drug Development | Regulatory Affairs
Why Otsuka Outsourced Regulatory Affairs
How outsourcing regulatory affairs gave Otsuka flexibility to move products through the development process faster.Online Exclusives Kristin Brooks, Managing Editor 08.09.18
-
Bio News | Collaborations & Alliances | Drug Development | Industry News
Allergan, Editas Announce Exercise of Development Options
Allergan has exercised its option to develop and commercialize EDIT-101 globally for the treatment of LCA1008.07.18
-
Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Jazz, University of Texas Enter Collaboration
The five year partnership has a goal of evaluating therapies for multiple hematologic malignancies08.07.18
-
Drug Development | Industry News
Gemphire, Pfizer Amend Gemcabene License
Extends the deadline for the first commercial sale to April 202408.07.18
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Oxford BioMedica Enters Three-way Cystic Fibrosis Partnership
Teams up with UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations08.06.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Regeneron, bluebird bio Form Cancer Collaboration
Aim to discover, develop and commercialize new cell therapies for cancer08.06.18
-
Bio News | Clinical Trials | Drug Development | Drug Discovery | Industry News | R&D | Trials & Filings
Denali Announces Positive Phase I Study Results
The study involved DNL201, a small molecule inhibitor of leucine-rich repeat kinase 208.03.18
-
Bio News | Drug Development | Drug Discovery | Industry News | R&D | Trials & Filings
EMA Grants Roche's RG6042 PRIME
The investigational medicine RG6042, formerly known as IONIS-HTTRx, is for the treatment of people with Huntington's disease08.03.18
-
Collaborations & Alliances | Drug Development
Forge Therapeutics Achieves CARB-X Milestone
Is now eligible to receive as much as $4 million in additional support to advance novel IV/Oral LpxC antibiotic08.01.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Formulation Development | Industry News | R&D
Innovate UK Grants Phico £1.4M
To support the manufacturing development of its intravenous antibiotic, SASPject PT3.808.01.18
-
Bio News | Clinical Trials | Drug Development | Industry News | R&D | Trials & Filings
Theravance Announces Positive Phase II Results
For TD-9855, a once-daily norepinephrine & serotonin reuptake inhibitor in development for treatment of symptomatic nOH08.01.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Vasomune, AnGes Sign Global Agreement
For the development & commercialization of treatments for diseases tied to with blood vessel dysfunction & destabilization07.31.18
-
Bio News | Drug Development | Industry News | Trials & Filings
Roche Receives Another FDA Approval
For the cobas® HPV Test to be used as the first-line screening test for cervical cancer in women 25 and older07.30.18
-
Bio News | Drug Development | Facilities | Industry News | R&D
Crown Bio Announces Expansion
Of its existing portfolio of humanized drug target models (HuGEMM™) to its San Diego research facility07.27.18
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Industry News
Almac Launches GMP High Throughput Peptide Mfg. Service
Completes MHRA registration at its Technopole campus near Edinburgh, Scotland07.27.18
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Facilities | Industry News | R&D
DPS Group & TRIA Complete Moderna Facility
The 200,000 sq. ft. space consolidates elements of Moderna's development, operations and nearly 200 employees under one roofVideos
